$NEOL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOPHARM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEOPHARM INC. Get notifications about new insider transactions in NEOPHARM INC for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2009 | NEOL | NEOPHARM INC | Ali Shahid | Executive Vice Pres ... | Option Exercise | A | 0.08 | 75,000 | 5,625 | 75,000 | |
Mar 13 2009 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.07 | 25,000 | 1,750 | 5,377,826 | 5.4 M to 5.4 M (+0.47 %) |
Mar 13 2009 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.06 | 203,000 | 12,322 | 5,352,826 | 5.1 M to 5.4 M (+3.94 %) |
Mar 13 2009 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.04 | 22,000 | 909 | 5,149,826 | 5.1 M to 5.1 M (+0.43 %) |
Mar 13 2009 | NEOL | NEOPHARM INC | Birch Laurence | President, CEO and ... | Buy | P | 0.05 | 15,000 | 675 | 227,556 | 212.6 K to 227.6 K (+7.06 %) |
Mar 13 2009 | NEOL | NEOPHARM INC | Birch Laurence | President, CEO and ... | Buy | P | 0.04 | 10,000 | 400 | 212,556 | 202.6 K to 212.6 K (+4.94 %) |
Mar 13 2009 | NEOL | NEOPHARM INC | Birch Laurence | President, CEO and ... | Buy | P | 0.05 | 11,901 | 536 | 202,556 | 190.7 K to 202.6 K (+6.24 %) |
Feb 11 2009 | NEOL | NEOPHARM INC | Birch Laurence | President, CEO and ... | Option Exercise | A | 0.08 | 150,000 | 11,250 | 150,000 | |
Aug 26 2008 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Option Exercise | A | 0.42 | 75,000 | 31,125 | 75,000 | |
Aug 26 2008 | NEOL | NEOPHARM INC | Birch Laurence | President, CEO and ... | Option Exercise | A | 0.42 | 50,000 | 20,750 | 50,000 | |
Aug 26 2008 | NEOL | NEOPHARM INC | Becker Frank C | Director | Option Exercise | A | 0.42 | 50,000 | 20,750 | 50,000 | |
Aug 26 2008 | NEOL | NEOPHARM INC | Fox Bernard A | Director | Option Exercise | A | 0.42 | 50,000 | 20,750 | 50,000 | |
Aug 26 2008 | NEOL | NEOPHARM INC | FREIMAN PAUL E | Director | Option Exercise | A | 0.42 | 50,000 | 20,750 | 50,000 | |
Jun 09 2008 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.83 | 11,500 | 9,596 | 5,127,826 | 5.1 M to 5.1 M (+0.22 %) |
Jun 05 2008 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.72 | 25,000 | 17,988 | 5,116,326 | 5.1 M to 5.1 M (+0.49 %) |
Jun 05 2008 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.69 | 20,000 | 13,700 | 5,091,326 | 5.1 M to 5.1 M (+0.39 %) |
Jun 04 2008 | NEOL | NEOPHARM INC | Ali Shahid | Executive Vice Pres ... | Buy | P | 0.62 | 5,000 | 3,100 | 5,000 | 0 to 5 K |
Jun 03 2008 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.67 | 28,500 | 19,035 | 5,071,326 | 5 M to 5.1 M (+0.57 %) |
Jun 03 2008 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.61 | 9,600 | 5,901 | 5,042,826 | 5 M to 5 M (+0.19 %) |
Jun 02 2008 | NEOL | NEOPHARM INC | Fox Bernard A | Director | Buy | P | 0.61 | 4,000 | 2,440 | 70,791 | 66.8 K to 70.8 K (+5.99 %) |
May 30 2008 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.58 | 400 | 234 | 5,033,226 | 5 M to 5 M (+0.01 %) |
May 30 2008 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 0.59 | 30,000 | 17,613 | 5,032,826 | 5 M to 5 M (+0.60 %) |
May 29 2008 | NEOL | NEOPHARM INC | Birch Laurence | President, CEO and ... | Buy | P | 0.59 | 9,000 | 5,308 | 190,655 | 181.7 K to 190.7 K (+4.95 %) |
May 29 2008 | NEOL | NEOPHARM INC | Birch Laurence | President, CEO and ... | Buy | P | 0.59 | 1,000 | 590 | 181,655 | 180.7 K to 181.7 K (+0.55 %) |
Dec 17 2007 | NEOL | NEOPHARM INC | Becker Frank C | Director | Sell | S | 0.88 | 33,000 | 29,103 | 68,223 | 101.2 K to 68.2 K (-32.60 %) |
Aug 20 2007 | NEOL | NEOPHARM INC | Becker Frank C | Director | Grant | A | 0.00 | 50,761 | 0 | 50,761 | 0 to 50.8 K |
Aug 20 2007 | NEOL | NEOPHARM INC | FREIMAN PAUL E | Director | Grant | A | 0.00 | 50,761 | 0 | 50,761 | 0 to 50.8 K |
Aug 20 2007 | NEOL | NEOPHARM INC | Fox Bernard A | Director | Grant | A | 0.00 | 50,761 | 0 | 50,761 | 0 to 50.8 K |
Aug 20 2007 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Grant | A | 0.00 | 60,913 | 0 | 60,913 | 0 to 60.9 K |
Jun 20 2007 | NEOL | NEOPHARM INC | Birch Laurence | President and CEO | Grant | A | 0.00 | 180,665 | 0 | 180,665 | 0 to 180.7 K |
May 25 2007 | NEOL | NEOPHARM INC | HANSON ERICK E | Director | Sell | S | 1.45 | 12,459 | 18,066 | 2,768 | 15.2 K to 2.8 K (-81.82 %) |
May 25 2007 | NEOL | NEOPHARM INC | HANSON ERICK E | Director | Sell | S | 1.46 | 8,817 | 12,873 | 15,227 | 24 K to 15.2 K (-36.67 %) |
Mar 27 2007 | NEOL | NEOPHARM INC | Birch Laurence | President and CEO | Option Exercise | A | 1.90 | 300,000 | 570,000 | 300,000 | |
Dec 07 2006 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | Ex. V.P. - Chief Me ... | Option Exercise | A | 7.11 | 80,000 | 568,800 | 80,000 | |
Dec 07 2006 | NEOL | NEOPHARM INC | Walbert Timothy P | Ex. VP - Commercial ... | Option Exercise | A | 7.11 | 100,000 | 711,000 | 100,000 | |
Dec 07 2006 | NEOL | NEOPHARM INC | HERRERA GUILLERMO A | President and CEO | Option Exercise | A | 7.11 | 150,000 | 1,066,500 | 150,000 | |
Dec 07 2006 | NEOL | NEOPHARM INC | Pauli Ronald | Ex. V.P. and CFO | Option Exercise | A | 7.11 | 25,000 | 177,750 | 25,000 | |
Oct 17 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 7.94 | 5,000 | 39,681 | 5,002,826 | 5 M to 5 M (+0.10 %) |
Oct 16 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 7.48 | 5,000 | 37,399 | 4,997,826 | 5 M to 5 M (+0.10 %) |
Oct 13 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 7.20 | 5,000 | 36,024 | 4,992,826 | 5 M to 5 M (+0.10 %) |
Oct 12 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 6.64 | 5,000 | 33,190 | 4,987,826 | 5 M to 5 M (+0.10 %) |
Oct 11 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 6.81 | 5,000 | 34,050 | 4,982,826 | 5 M to 5 M (+0.10 %) |
Oct 06 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 5.58 | 10,000 | 55,820 | 4,977,826 | 5 M to 5 M (+0.20 %) |
Oct 06 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 5.47 | 5,000 | 27,329 | 4,967,826 | 5 M to 5 M (+0.10 %) |
Oct 06 2006 | NEOL | NEOPHARM INC | Pauli Ronald | Ex. V.P. - CFO | Buy | P | 5.60 | 2,000 | 11,200 | 2,000 | 0 to 2 K |
Oct 04 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 5.57 | 5,000 | 27,849 | 4,962,826 | 5 M to 5 M (+0.10 %) |
Oct 04 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 5.38 | 5,000 | 26,888 | 4,957,826 | 5 M to 5 M (+0.10 %) |
Sep 29 2006 | NEOL | NEOPHARM INC | Walbert Timothy P | Ex. V.P. - Comm. Op ... | Buy | P | 4.86 | 1,000 | 4,860 | 1,000 | 0 to 1,000 |
Sep 29 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 4.86 | 20,000 | 97,186 | 4,952,826 | 4.9 M to 5 M (+0.41 %) |
Sep 28 2006 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | Ex. VP - Chief Medi ... | Buy | P | 4.98 | 1,000 | 4,980 | 3,281 | 2.3 K to 3.3 K (+43.84 %) |
Sep 22 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 5.02 | 10,000 | 50,236 | 4,932,826 | 4.9 M to 4.9 M (+0.20 %) |
Sep 22 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman of the Boa ... | Buy | P | 4.97 | 10,000 | 49,667 | 4,922,826 | 4.9 M to 4.9 M (+0.20 %) |
Aug 29 2006 | NEOL | NEOPHARM INC | Pauli Ronald | Executive Vice Pres ... | Option Exercise | A | 5.17 | 75,000 | 387,750 | 75,000 | |
Aug 24 2006 | NEOL | NEOPHARM INC | SAFAVI KAVEH T | Director | Buy | P | 5.05 | 143 | 722 | 24,972 | 24.8 K to 25 K (+0.58 %) |
Aug 24 2006 | NEOL | NEOPHARM INC | SAFAVI KAVEH T | Director | Buy | P | 5.01 | 800 | 4,005 | 24,829 | 24 K to 24.8 K (+3.33 %) |
Aug 24 2006 | NEOL | NEOPHARM INC | SAFAVI KAVEH T | Director | Buy | P | 5.04 | 1,188 | 5,988 | 24,029 | 22.8 K to 24 K (+5.20 %) |
Aug 24 2006 | NEOL | NEOPHARM INC | SAFAVI KAVEH T | Director | Buy | P | 5.06 | 1,751 | 8,860 | 22,841 | 21.1 K to 22.8 K (+8.30 %) |
Jun 26 2006 | NEOL | NEOPHARM INC | HERRERA GUILLERMO A | President and CEO | Buy | P | 5.00 | 40,000 | 200,000 | 62,075 | 22.1 K to 62.1 K (+181.20 %) |
Jun 21 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman | Grant | A | 0.00 | 11,326 | 0 | 21,749 | 10.4 K to 21.7 K (+108.66 %) |
Jun 21 2006 | NEOL | NEOPHARM INC | SAFAVI KAVEH T | Director | Grant | A | 0.00 | 8,090 | 0 | 21,331 | 13.2 K to 21.3 K (+61.10 %) |
Jun 21 2006 | NEOL | NEOPHARM INC | Eidell Ronald G | Director | Grant | A | 0.00 | 8,090 | 0 | 22,082 | 14 K to 22.1 K (+57.82 %) |
Jun 21 2006 | NEOL | NEOPHARM INC | HANSON ERICK E | Director | Grant | A | 0.00 | 8,090 | 0 | 24,285 | 16.2 K to 24.3 K (+49.95 %) |
Jun 21 2006 | NEOL | NEOPHARM INC | FREIMAN PAUL E | Director | Grant | A | 0.00 | 8,090 | 0 | 15,671 | 7.6 K to 15.7 K (+106.71 %) |
Jun 21 2006 | NEOL | NEOPHARM INC | Fox Bernard A | Director | Grant | A | 0.00 | 8,090 | 0 | 16,271 | 8.2 K to 16.3 K (+98.89 %) |
Jun 21 2006 | NEOL | NEOPHARM INC | Becker Frank C | Director | Grant | A | 0.00 | 8,090 | 0 | 50,703 | 42.6 K to 50.7 K (+18.98 %) |
Jan 27 2006 | NEOL | NEOPHARM INC | KENYON LAWRENCE A | CFO and Secretary | Option Exercise | A | 12.46 | 25,000 | 311,500 | 25,000 | |
Jan 27 2006 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | Executive V.P. | Option Exercise | A | 12.46 | 25,000 | 311,500 | 25,000 | |
Jan 27 2006 | NEOL | NEOPHARM INC | AHMAD IMRAN | Executive V.P. | Option Exercise | A | 12.46 | 25,000 | 311,500 | 25,000 | |
Jan 19 2006 | NEOL | NEOPHARM INC | Walbert Timothy P | Ex. VP Comm.Ops | Option Exercise | A | 12.02 | 75,000 | 901,500 | 75,000 | |
Jan 06 2006 | NEOL | NEOPHARM INC | Eidell Ronald G | Director | Buy | P | 10.20 | 4,900 | 49,980 | 13,992 | 9.1 K to 14 K (+53.89 %) |
Jan 06 2006 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Director | Buy | P | 10.20 | 200,000 | 2,040,000 | 1,418,231 | 1.2 M to 1.4 M (+16.42 %) |
Nov 01 2005 | NEOL | NEOPHARM INC | HERRERA GUILLERMO A | President and CEO | Option Exercise | A | 9.06 | 500,000 | 4,530,000 | 500,000 | |
Nov 01 2005 | NEOL | NEOPHARM INC | HERRERA GUILLERMO A | President and CEO | Grant | A | 0.00 | 22,075 | 0 | 22,075 | 0 to 22.1 K |
Nov 01 2005 | NEOL | NEOPHARM INC | Eidell Ronald G | Director | Grant | A | 0.00 | 3,492 | 0 | 9,092 | 5.6 K to 9.1 K (+62.36 %) |
Sep 27 2005 | NEOL | NEOPHARM INC | Becker Frank C | Chairman | Buy | P | 11.91 | 28,000 | 333,480 | 42,613 | 14.6 K to 42.6 K (+191.61 %) |
Aug 02 2005 | NEOL | NEOPHARM INC | Fox Bernard A | Director | Buy | P | 8.59 | 600 | 5,154 | 8,181 | 7.6 K to 8.2 K (+7.91 %) |
Jun 20 2005 | NEOL | NEOPHARM INC | SAFAVI KAVEH T | Director | Grant | A | 0.00 | 5,081 | 0 | 13,241 | 8.2 K to 13.2 K (+62.27 %) |
Jun 20 2005 | NEOL | NEOPHARM INC | FREIMAN PAUL E | Director | Grant | A | 0.00 | 5,081 | 0 | 7,581 | 2.5 K to 7.6 K (+203.24 %) |
Jun 20 2005 | NEOL | NEOPHARM INC | Becker Frank C | Chairman of Board | Grant | A | 0.00 | 7,113 | 0 | 14,613 | 7.5 K to 14.6 K (+94.84 %) |
Jun 20 2005 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Director | Grant | A | 0.00 | 5,081 | 0 | 10,423 | 5.3 K to 10.4 K (+95.11 %) |
Jun 20 2005 | NEOL | NEOPHARM INC | Fox Bernard A | Director | Grant | A | 0.00 | 5,081 | 0 | 7,581 | 2.5 K to 7.6 K (+203.24 %) |
Jun 20 2005 | NEOL | NEOPHARM INC | HANSON ERICK E | Director | Grant | A | 0.00 | 5,081 | 0 | 16,195 | 11.1 K to 16.2 K (+45.72 %) |
May 02 2005 | NEOL | NEOPHARM INC | KENYON LAWRENCE A | CFO and Secretary | Option Exercise | A | 7.95 | 43,100 | 342,645 | 43,100 | |
May 02 2005 | NEOL | NEOPHARM INC | AHMAD IMRAN | Executive V.P. | Option Exercise | A | 7.95 | 35,400 | 281,430 | 35,400 | |
May 02 2005 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | Executive V.P. | Option Exercise | A | 7.95 | 29,100 | 231,345 | 29,100 | |
Mar 15 2005 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Director | Buy | P | 8.10 | 500 | 4,050 | 4,712,826 | 4.7 M to 4.7 M (+0.01 %) |
Mar 15 2005 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Director | Buy | P | 8.06 | 18,000 | 145,080 | 4,712,326 | 4.7 M to 4.7 M (+0.38 %) |
Mar 15 2005 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Director | Buy | P | 8.23 | 50,000 | 411,500 | 4,694,326 | 4.6 M to 4.7 M (+1.08 %) |
Mar 14 2005 | NEOL | NEOPHARM INC | Eidell Ronald G | President and CEO | Option Exercise | A | 7.95 | 80,000 | 636,000 | 80,000 | |
Mar 14 2005 | NEOL | NEOPHARM INC | Eidell Ronald G | President and CEO | Buy | P | 8.00 | 1,000 | 8,000 | 5,600 | 4.6 K to 5.6 K (+21.74 %) |
Mar 14 2005 | NEOL | NEOPHARM INC | HANSON ERICK E | Chairman | Buy | P | 8.28 | 731 | 6,053 | 11,114 | 10.4 K to 11.1 K (+7.04 %) |
Mar 14 2005 | NEOL | NEOPHARM INC | HANSON ERICK E | Chairman | Buy | P | 8.27 | 2,223 | 18,384 | 10,383 | 8.2 K to 10.4 K (+27.24 %) |
Feb 11 2005 | NEOL | NEOPHARM INC | Eidell Ronald G | Director | Buy | P | 11.95 | 2,100 | 25,095 | 4,600 | 2.5 K to 4.6 K (+84.00 %) |
Dec 03 2004 | NEOL | NEOPHARM INC | Binion Steven B | V.P. Regulatory Aff ... | Option Exercise | A | 11.45 | 50,000 | 572,500 | 50,000 | |
Dec 02 2004 | NEOL | NEOPHARM INC | Fox Bernard A | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Dec 02 2004 | NEOL | NEOPHARM INC | FREIMAN PAUL E | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Dec 02 2004 | NEOL | NEOPHARM INC | Eidell Ronald G | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Dec 02 2004 | NEOL | NEOPHARM INC | Eidell Ronald G | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Dec 02 2004 | NEOL | NEOPHARM INC | Becker Frank C | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
Nov 15 2004 | NEOL | NEOPHARM INC | ROGAN MATTHEW P | Director | Option Exercise | J | 13.78 | 11,500 | 158,500 | 11,500 | |
Nov 15 2004 | NEOL | NEOPHARM INC | ROGAN MATTHEW P | Director | Option Exercise | J | 13.78 | 11,500 | 158,500 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | ROGAN MATTHEW P | Director | Option Exercise | J | 22.83 | 9,487 | 216,550 | 9,487 | |
Nov 15 2004 | NEOL | NEOPHARM INC | ROGAN MATTHEW P | Director | Option Exercise | J | 22.83 | 9,487 | 216,550 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | ROGAN MATTHEW P | Director | Option Exercise | J | 14.97 | 6,325 | 94,687 | 6,325 | |
Nov 15 2004 | NEOL | NEOPHARM INC | ROGAN MATTHEW P | Director | Option Exercise | J | 14.97 | 6,325 | 94,687 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 13.78 | 11,500 | 158,500 | 11,500 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 13.78 | 11,500 | 158,500 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 22.83 | 9,487 | 216,550 | 9,487 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 22.83 | 9,487 | 216,550 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 14.97 | 6,325 | 94,687 | 6,325 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 14.97 | 6,325 | 94,687 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 14.62 | 6,325 | 92,500 | 6,325 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 14.62 | 6,325 | 92,500 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 13.78 | 11,500 | 158,500 | 11,500 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 13.78 | 11,500 | 158,500 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 22.83 | 9,487 | 216,550 | 9,487 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 22.83 | 9,487 | 216,550 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 14.97 | 6,325 | 94,687 | 6,325 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 14.97 | 6,325 | 94,687 | 0 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 14.62 | 6,325 | 92,500 | 6,325 | |
Nov 15 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Option Exercise | J | 14.62 | 6,325 | 92,500 | 0 | |
Jul 13 2004 | NEOL | NEOPHARM INC | YOUNG GREGORY P | President and CEO | Option Exercise | A | 7.89 | 250,000 | 1,972,500 | 250,000 | |
Jun 24 2004 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Director | Grant | A | 0.00 | 5,342 | 0 | 4,681,293 | 4.7 M to 4.7 M (+0.11 %) |
May 19 2004 | NEOL | NEOPHARM INC | HUSSEY JAMES M | President and CEO | Option Exercise | M | 3.75 | 50,000 | 187,745 | 329,500 | |
May 19 2004 | NEOL | NEOPHARM INC | HUSSEY JAMES M | President and CEO | Gift | G | 0.00 | 22,100 | 0 | 701,524 | 723.6 K to 701.5 K (-3.05 %) |
May 19 2004 | NEOL | NEOPHARM INC | HUSSEY JAMES M | President and CEO | Sell | S | 14.06 | 27,900 | 392,394 | 701,524 | 729.4 K to 701.5 K (-3.82 %) |
May 19 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | EX. VP | Gift | G | 0.00 | 100 | 0 | 214,186 | 214.3 K to 214.2 K (-0.05 %) |
May 19 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | EX. VP | Buy | P | 14.06 | 100 | 1,406 | 214,186 | 214.1 K to 214.2 K (+0.05 %) |
May 19 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | EX. VP | Gift | G | 0.00 | 100 | 0 | 214,186 | 214.3 K to 214.2 K (-0.05 %) |
May 19 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | EX. VP | Buy | P | 14.06 | 100 | 1,406 | 214,186 | 214.1 K to 214.2 K (+0.05 %) |
Mar 12 2004 | NEOL | NEOPHARM INC | SAFAVI KAVEH T | Director | Grant | A | 0.00 | 2,410 | 0 | 8,160 | 5.8 K to 8.2 K (+41.91 %) |
Mar 12 2004 | NEOL | NEOPHARM INC | ROGAN MATTHEW P | Director | Grant | A | 0.00 | 2,410 | 0 | 8,160 | 5.8 K to 8.2 K (+41.91 %) |
Mar 12 2004 | NEOL | NEOPHARM INC | HANSON ERICK E | Director | Grant | A | 0.00 | 2,410 | 0 | 8,160 | 5.8 K to 8.2 K (+41.91 %) |
Mar 12 2004 | NEOL | NEOPHARM INC | HANSON ERICK E | Director | Grant | A | 0.00 | 2,410 | 0 | 8,160 | 5.8 K to 8.2 K (+41.91 %) |
Mar 12 2004 | NEOL | NEOPHARM INC | FLAUM SANDER A | Director | Grant | A | 0.00 | 2,410 | 0 | 17,015 | 14.6 K to 17 K (+16.50 %) |
Mar 11 2004 | NEOL | NEOPHARM INC | KAPOOR JOHN N TRUST LTD | Chairman | Buy | J | 15.36 | 405 | 6,221 | 1,148,340 | 1.1 M to 1.1 M (+0.04 %) |
Mar 11 2004 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman | Sell | J | 15.36 | 405 | 6,221 | 1,958,180 | 2 M to 2 M (-0.02 %) |
Mar 11 2004 | NEOL | NEOPHARM INC | KAPOOR JOHN N | Chairman | Buy | J | 15.36 | 405 | 6,221 | 1,148,340 | 1.1 M to 1.1 M (+0.04 %) |
Mar 11 2004 | NEOL | NEOPHARM INC | KAPOOR JOHN N 1994 A ANNUITY T ... | Chairman | Sell | J | 15.35 | 405 | 6,217 | 1,958,180 | 2 M to 2 M (-0.02 %) |
Feb 18 2004 | NEOL | NEOPHARM INC | AHMAD IMRAN | Sr VP-R&D,Chief Sci ... | Option Exercise | A | 19.91 | 30,000 | 597,300 | 30,000 | |
Feb 18 2004 | NEOL | NEOPHARM INC | KENYON LAWRENCE A | CFO & Secretary | Option Exercise | A | 19.91 | 20,000 | 398,200 | 20,000 | |
Feb 18 2004 | NEOL | NEOPHARM INC | SHERMAN JEFFREY W | Ex VP & Chief Medic ... | Option Exercise | A | 19.91 | 30,000 | 597,300 | 30,000 | |
Feb 18 2004 | NEOL | NEOPHARM INC | HUSSEY JAMES M | CEO | Option Exercise | A | 19.91 | 120,000 | 2,389,200 | 120,000 |
Page: 1